Bloomberg Technology

TMRW Life Sciences Modernizes In Vitro Fertilization

Jul.21 — TMRW Life Sciences Inc CEO Tara Comonte explains how her company uses technology to advance in vitro fertilization. She also talks about her company raising $105 million in series C funding. She speaks with Caroline Hyde on “Bloomberg Technology.”

Published

3 years ago

on

Jul.21 — TMRW Life Sciences Inc CEO Tara Comonte explains how her company uses technology to advance in vitro fertilization. She also talks about her company raising $105 million in series C funding. She speaks with Caroline Hyde on “Bloomberg Technology.”

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version